While pretreatment percentages of CD4+PD-1+Tim-3+ T-cells, and CD8+PD-1+Tim-3+ T-cells in all three fibrosis groups were significantly higher than in healthy controls (Figs. 5 and 6), there were no differences between patients with different fibrosis stage. Here, HAVCR2 is linked to fibrosis.